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Abstract 
Objectives: To identify characteristics associated with obtaining HIV and syphilis screenings of pregnant women 
attending a first antenatal visit in Lusaka, Zambia.
Results: Among 18,231 participants from April 2015 to January 2016, 95% obtained HIV screening, 29% obtained 
syphilis screening, and 4% did not obtain antenatal HIV or syphilis screenings. Divorced/separated women were asso-
ciated with a moderate decrease in prevalence of obtaining HIV (adjusted prevalence ratio (aPR) 0.88, 95% confidence 
interval (95% CI) 0.82, 0.95) and syphilis (aPR 0.51, 95% CI 0.27, 0.96) screenings compared to married women. Women 
with previous pregnancies were associated with a slight decrease in prevalence of obtaining HIV screening (aPR 
0.97, 95% CI 0.95, 0.99) compared to women without previous pregnancy. Older women ≥ 35 years were associated 
with a slight decrease in prevalence of obtaining HIV screening (aPR 0.96, 95% CI 0.92, 0.99) compared to younger 
women. The statistically significant differences were not of clinical relevance as defined by a proportional difference 
of 10 percent. Findings of this study show that a vast majority of pregnant women are obtaining HIV screenings but 
not syphilis screenings during first antenatal visit. Provision of antenatal HIV and syphilis screening at first visit is only 
weakly related to patient level factors.
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Introduction
Despite advances in antenatal recommendations and 
treatment to prevent mother to child transmission 
(PMTCT) of HIV and syphilis, congenital infections 
represent a major global public health burden. The most 
effective method of prevention of mother to child trans-
mission of HIV is to reduce maternal viral load through 
antiretroviral therapy (ART) during pregnancy and 
breastfeeding [1]. Without provision of antiretroviral 
treatment, the rate of vertical transmission of HIV can 
range from 15 to 45% [2, 3]. For prevention of congenital 
syphilis, one dose of benzathine penicillin G is effective 
treatment to prevent mother to child transmission of 
syphilis [4]. A single dose is sufficient to treat early syphi-
lis, but syphilis of longer duration requires three doses 
to assure cure. Untreated syphilis can lead to fetal loss 
or stillbirth during pregnancy and surviving infants can 
be born preterm, low birth weight, or have active syphi-
lis infection [5]. In addition, syphilis positive pregnant 
women are twice as likely to be HIV seropositive [6].
Antenatal screenings are a key step in prevention of 
HIV and syphilis transmission in order to identify sero-
positive women and start respective treatments [7, 8]. A 
focus on both HIV and syphilis screening during ante-
natal care has proven to be feasible, cost-effective, and 
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women attending antenatal care in sub-Saharan Africa, 
approximately 60% of pregnant women received HIV 
testing and under 40% of pregnant women received syph-
ilis testing [13, 14]. Specifically in Zambia, HIV screening 
of pregnant women was estimated to be 94% and syphilis 
screening was 85% during 2010–2013 [15].
Antenatal HIV and syphilis screenings are not univer-
sal in Zambia and greater sub-Saharan Africa [13, 16, 17]. 
Exploring individual level characteristics associated with 
antenatal HIV and syphilis screenings can better describe 
the current situation and assist with creating more tar-
geted interventions to increase the provision of ante-
natal screenings. Previous studies have reported mixed 
findings on the association between women obtaining 
antenatal HIV and syphilis screenings during pregnancy 
and individual level characteristics such as age, adverse 
pregnancy outcomes, and marital status [18–22]. In 
addition, prior research focused on individual level fac-
tors associated with antenatal HIV or syphilis screenings 
have reported findings on either antenatal HIV or syphi-
lis screenings. The objective of this present study was to 
identify clinically relevant individual factors associated 




This is a cross-sectional study focusing on 13 Lusaka 
district clinics participating in the nine month baseline 
period of Preventing Congenital Syphilis (PCS), a facility-
based, two-arm parallel cluster randomized implementa-
tion trial (ClinicalTrials.gov: NCT02353117; registered 
on February 2, 2015) [23]. The objective of the PCS 
implementation trial was to evaluate a behavioral mul-
tifaceted intervention to increase the use of evidence-
based clinical procedures to increase syphilis screening 
and treatment during antenatal care in antenatal clin-
ics in Kinshasa, Democratic Republic of the Congo and 
Lusaka, Zambia [24, 25].
The 13 antenatal clinics participating in the baseline 
period were selected based on geographic location within 
areas of Kafue and Chongwe located in the capital prov-
ince of Lusaka. These health facilities that are designated 
as urban health centers with PMTCT programs in Lusaka 
District (91). During the baseline period, all women 
attending their first antenatal care visit at one of the 13 
participating clinics during April 13, 2015 to January 10, 
2016 were approached for study enrollment [24].
The inclusion criterion for this study included all con-
senting women who attended an antenatal care visit 
for the first time at one of the participating clinics in 
Lusaka, Zambia from April 2015 to January 2016 and 
recorded within the PCS baseline database. Women with 
completed data were included in the analyses. Antenatal 
care is defined as care during pregnancy before the initia-
tion of labor. A first antenatal care visit is defined as the 
first visit at a participating health care facility during the 
current pregnancy. Exclusion criteria included women 
who did not/were unable to provide consent.
For enrolled participants, study personnel completed 
an antenatal care form at clinics [24]. Data was also 
collected from multiple source documents including 
antenatal care registry, antenatal card, PMTCT books, 
laboratory records, and nurses’ books [24]. Unavailable 
data from the source documents were collected from the 
mothers [24]. During the baseline data period, the study 
team produced detailed weekly and monthly data moni-
toring reports. Weekly calls and monitoring visits were 
made to continuously monitor study activities and data 
quality.
Statistical analyses
The unit of data analysis is a pregnant woman. Data are 
summarized as count and percentage for all categorical 
variables. Log-binomial regression model with adjust-
ment for cluster effects was used to estimate crude prev-
alence ratios (PR) with 95% confidence intervals (95% 
CI) and adjusted prevalence ratios (aPR) with 95% CI 
to determine which individual level factors were associ-
ated with the following dichotomous screening outcomes 
during first antenatal visit: (1) obtained HIV screen-
ing vs. no HIV screening (reference group (ref )) and 
(2) obtained syphilis screening vs. no syphilis screening 
(ref ). Separate crude and adjusted PRs were calculated 
for variables pertaining to HIV and/or syphilis screen-
ings among pregnant women with history of previous 
pregnancy using Poisson regression models with robust 
variance and adjustment for cluster effects. All aPRs and 
95% CIs were adjusted for age, marital status, education, 
history of known syphilis infection, and previous preg-
nancy. These variables were selected a priori based on the 
existing literature [13, 26, 27]. All statistical analyses were 
conducted using SAS 9.4 (SAS Institute Inc., Cary, NC). 
Clinical relevance was defined by a proportional differ-
ence of 10 percent [28].
Results
This study included 18,231 pregnant women. During 
first antenatal care visit, 95% of women obtained an HIV 
screening, 29% of women obtained a syphilis screening, 
and 4% of women did not obtain antenatal HIV or syphi-
lis screening. Majority of the study participants were 
between 20 and 34  years of age (76%), married (88%), 
completed greater than primary school to less than or 
equal secondary school (55%), and had no history of 
syphilis infection (98%) (Table 1). Of the 13,396 women 
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with previous pregnancy, 17% had a history of preterm 
birth, and 4% had a history of previous abortion and/or 
stillbirth (Table 1).
Majority of pregnant women had obtained HIV screen-
ing among all variable levels of age, marital status, educa-
tion, history of syphilis infection, and previous pregnancy 
during first antenatal care visit in Lusaka, Zambia 
(Table 2). In multivariable regression analyses, pregnant 
women who were greater than or equal to 35  years of 
age (aPR = 0.96; 95% CI (0.92, 0.99)), divorced/separated 
(aPR = 0.88; 95% CI (0.82, 0.95)), had a history of syphilis 
infection (aPR 1.07, 95% CI 1.01, 1.15), and two or more 
previous pregnancies (aPR = 0.97; 95% CI (0.95–0.99)) 
were significantly associated with a decreased prevalence 
of obtaining an HIV screening.
Majority of pregnant women did not obtain a syphilis 
screening at first antenatal visit among all variable levels 
of age, marital status, education, history of syphilis infec-
tion, and previous pregnancy during first antenatal care 
visit in Lusaka, Zambia (Table 3). Widowed women with-
out a current partner were associated with an increase in 
prevalence of obtaining syphilis screening (aPR 1.49, 95% 
Table 1 Overall characteristics of pregnant women attending first antenatal care visit in Lusaka, Zambia, 2015–2016
Characteristics n = 18,231 %
Screening status
 HIV screening only 12,340 67.7
 Syphilis screening only 192 1.1
 HIV screening and syphilis screening 5004 27.5
 Neither syphilis or HIV 664 3.6
Age
 < 20 2456 13.5
 20–34 13,792 75.7
 ≥ 35 1983 10.9
Marital status
 Married/with a partner 16,084 88.2
 Single 2037 11.2
 Widowed without current partner 55 0.3
 Divorced/separated 55 0.3
Education
 ≤ Primary complete 6625 36.3
 Greater than primary complete to ≤ secondary school 9999 54.9
 Greater than secondary school 1607 8.8
History of syphilis screening
 Yes 404 2.2
 No 17,827 97.8
Number of previous pregnancies
 0 4835 26.5
 1 4679 25.7
 2 3671 20.1
 3 2498 13.7
 ≥ 4 2548 14.0
Women with previous pregnancy n = 13,300 %
Previous preterm
 0 12,790 96.2
 1 431 3.2
 ≥ 2 79 0.6
Previous abortions and/or stillbirths
 0 11,122 83.6
 1 1756 13.2
 ≥ 2 422 3.2
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CI 1.08, 2.05) compared to married women. Conversely, 
divorced/separated women had a decrease in prevalence 
of obtaining syphilis screening (aPR 0.51, 95% CI 0.27, 
0.96) compared to married women.
Discussion
Provision of screenings during the first antenatal care 
visit is essential to prevent vertical transmission of 
HIV and syphilis. However, antenatal HIV and syphi-
lis screening rates vary dramatically across sub-Saharan 
Africa. Despite evidence demonstrating the cost-effec-
tiveness and beneficial effects of prioritizing both 
antenatal HIV and syphilis screenings, previous studies 
have focused on individual level factors associated with 
either antenatal HIV or syphilis screenings. The current 
study is one of few that has investigated both types of 
antenatal screenings concurrently. Results of this study 
showed that only 29% of pregnant women obtained a 
syphilis screening compared to 95% of pregnant women 
who obtained HIV screening at first antenatal visit 
during the baseline period of the PCS implementation 
trial. Furthermore, the regression analysis showed lim-
ited clinically relevant individual level gaps in antenatal 
HIV and syphilis screenings among pregnant women 
Table 2 Individual-level characteristics and  prevalence ratios for  the  outcome: pregnant women who obtained a  HIV 
screening
a Adjusted prevalence ratios (aPR) and 95% confidence intervals (95% CI) were adjusted for age, marital status, education, history of known syphilis infection, and 
previous pregnancy
Characteristics HIV Screened, 
n = 17,374
HIV Screened, % PR (95% CI) aPRa (95% CI)
Age
 < 20 2406 98.0 Ref Ref
 20–34 13,168 95.5 0.97 (0.96, 0.99) 0.99 (0.98, 1.00)
 ≥ 35 1800 90.8 0.93 (0.89, 0.96) 0.96 (0.92, 0.99)
Marital status
 Married/with a partner 15,312 95.2 Ref Ref
 Single 1972 96.8 1.02 (1.01, 1.03) 1.00 (0.99, 1.01)
 Widowed without current partner 44 80.0 0.84 (0.65, 1.08) 0.86 (0.67, 1.09)
 Divorced/separated 46 83.6 0.88 (0.82, 0.94) 0.88 (0.82, 0.95)
Education
 ≤ Primary complete 6227 94.0 Ref Ref
 > Primary complete to ≤ Secondary school 9589 95.9 1.02 (1.01, 1.03) 1.01 (1.00, 1.02)
 > Secondary school 1558 97.0 1.03 (1.01, 1.05) 1.02 (1.00, 1.04)
History of syphilis infection
 No 17,017 95.5 Ref Ref
 Yes 357 88.4 1.08 (1.01, 1.16) 1.07 (1.01, 1.15)
Previous pregnancy
 0 4733 97.9 Ref Ref
 1 4495 96.1 0.98 (0.97, 0.99) 0.99 (0.98, 1.00)
 2 3461 94.3 0.96 (0.94, 0.98) 0.97 (0.95, 0.99)
 3 2338 93.6 0.96 (0.93, 0.98) 0.97 (0.95, 0.99)
 ≥ 4 2347 92.1 0.94 (0.92, 0.97) 0.97 (0.95, 0.98)
Women with ≥ 1 previous pregnancy n = 12,544 % PR (95% CI) aPRa (95% CI)
Previous preterm births
 0 12,077 94.4 Ref Ref
 1 392 91.0 0.97 (0.94, 0.99) 0.97 (0.94, 1.00)
 ≥ 2 75 94.9 0.99 (0.93, 1.05) 1.00 (0.94, 1.06)
Previous abortions and/or stillbirths
 0 10,501 94.4 Ref Ref
 1 1653 94.1 0.99 (0.98, 1.01) 1.00 (0.98, 1.02)
 ≥ 2 390 92.4 0.97 (0.93, 1.01) 0.99 (0.95, 1.02)
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attending a first visit. This is a positive finding in that 
provision of antenatal HIV and syphilis screenings by 
healthcare providers do not greatly differ by individual 
patient characteristics.
Education was the most common individual level fac-
tor assessed in previous studies. Multiple studies found 
that higher education among pregnant women was sig-
nificantly associated with obtaining antenatal HIV and 
syphilis screenings [18–22]. The present study did not 
find a significant association between education level 
and screenings. Majority of participants in this study 
had received more than a primary education.
In the current study, the results showed a large gap 
between antenatal syphilis screenings and HIV screening 
at first visit which could not be attributed to individual 
level factors. The results of the PCS implementation trial 
showed that a multifaceted behavioral intervention with 
provision of supplies, including screening and treatment 
kits, can lead to more than 95% of pregnant women being 
screened and treated for syphilis without compromising 
HIV screening rates in Lusaka, Zambia and Kinshasa, 
Democratic Republic of the Congo [25]. Improvement of 
clinic-level factors demonstrated an increase in the provi-
sion of antenatal syphilis screenings. The findings of this 
Table 3 Individual-level characteristics and prevalence ratios for the outcome: pregnant women who obtained a syphilis 
screening
a Adjusted prevalence ratio (aPR) and 95% confidence intervals (95% CI) were adjusted for age, marital status, education, history of known syphilis infection, and 
previous pregnancy
Characteristics Syphilis screened, 
n = 5196
Syphilis screened, % PR (95% CI) aPRa (95% CI)
Age
 < 20 711 29.0 Ref Ref
 20–34 3940 28.6 0.99 (0.88, 1.11) 0.99 (0.88, 1.11)
 ≥35 545 27.5 0.95 (0.83, 1.09) 0.96 (0.83, 1.12)
Marital status
 Married/with a partner 4638 28.8 Ref Ref
 Single 527 25.9 0.90 (0.73, 1.10) 0.87 (0.71, 1.06)
 Widowed without current partner 23 41.8 1.45 (1.05, 1.99) 1.49 (1.08, 2.05)
 Divorced/separated 8 14.6 0.50 (0.27, 0.95) 0.51 (0.27, 0.96)
Education
 ≤ Primary complete 1806 27.3 Ref Ref
 >Primary complete to ≤ secondary school 2971 29.7 1.09 (0.87, 1.37) 1.09 (0.87, 1.37)
 > Secondary school 419 26.1 0.96 (0.67, 1.36) 0.96 (0.68, 1.36)
History of syphilis infection
 No 5091 28.6 Ref Ref
 Yes 105 26.0 1.10 (0.92, 1.31) 1.09 (0.93, 1.27)
Previous pregnancy
 0 1398 28.9 Ref Ref
 1 1342 28.7 0.99 (0.91, 1.08) 0.97 (0.89, 1.06)
 2 1051 28.6 0.99 (0.91, 1.08) 0.97 (0.89, 1.06)
 3 695 27.8 0.96 (0.84, 1.10) 0.95 (0.83, 1.09)
 ≥ 4 710 27.9 0.96 (0.84, 1.10) 0.97 (0.89, 1.06)
Women with ≥ 1 previous pregnancy n = 3781 % PR (95% CI) aPRa (95% CI)
Previous preterm births
 0 3610 28.2 Ref Ref
 1 143 33.2 0.98 (0.94, 1.02) 0.98 (0.94, 1.03)
 ≥ 2 28 35.4 1.02 (0.98, 1.06) 1.03 (0.98, 1.08)
Previous abortions and/or stillbirths
 0 3146 28.3 Ref Ref
 1 522 29.7 1.02 (1.00, 1.03) 1.02 (1.00, 1.03)
 ≥ 2 113 26.8 0.97 (0.93, 1.01) 0.97 (0.94, 1.01)
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study should be used to supplement the findings from 
the PCS implementation trial to inform future antenatal 
staff trainings, patient education, and future interven-
tions that focus on scaling up antenatal HIV and syphilis 
screenings.
Limitations
The findings of this study should be interpreted with 
consideration of study limitations. The cross-sectional 
design of this study prevents any causal interpretation 
of the significant associations. The variables available 
for this secondary analysis were limited and methods of 
data collection are not specifically designed for the pur-
poses of this cross-sectional study. Although this study 
has a large sample size, because the health facilities were 
not randomly selected for the PCS baseline period, gen-
eralizability of the study findings should be limited to 
women attending first antenatal care visit at public clin-
ics in Lusaka district. The findings of this study may also 
be subject to recall bias as the variables not recorded 
in clinic source documents are based on self-reports to 
trained study personnel without verification. Further-
more, the study is also susceptible to social desirability 
bias as the data collected by research staff reveal medical 
history and personal information on HIV and syphilis in 
pregnant women.
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